Skip to main content

Michael Cosgrove, Robert Saltmarsh, and Michael Nemzek

Premium

Michael Cosgrove, formerly director of enterprise systems at image informatics firm Scimagix, has left the company, according to BioInform, an Inside Bioassays sister publication. Scimagix was acquired by image analysis software firm BioImagene in November. Cosgrove said he is “currently exploring other opportunities within the bioinformatics arena.”


Robert Saltmarsh has been promoted to chief financial officer of Nanogen, the San Diego-based company said last week.

Saltmarsh joined Nanogen as vice president of corporate development in September. Most recently, he was a consultant for several start-up companies and taught entrepreneurial finance at the University of California at Riverside. Saltmarsh holds a BA in economics and an MBA in finance from the University of Michigan.


Michael Nemzek joined Velocity11 of Menlo Park, Calif., as vice president of marketing, the company said last week. Nemzek previously was general manager of discovery tools at Symyx Technologies. Prior to that, Nemzek was an executive with Cellomics; Genosys Biotechnologies (now part of Sigma-Aldrich); Tropix (now part of Applied Biosystems); and EG&G (now part of PerkinElmer). Velocity11 develops automation technologies for pharma/biotech and genomics labs.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.